Introduction
============

Epiretinal membrane (ERM) and taut posterior hyaloid (TPH) are vitreoretinal interface diseases that may develop as complications of diabetic maculopathy and/or retinopathy. Pars plana vitrectomy (PPV) is generally accepted as the treatment modality.[@b1-opth-9-1483] Accompanying internal limiting membrane (ILM) peeling would also allow for the removal of the contractile membranes with consequent elimination of any tangential tractional forces, thus leading to resolution of the macular edema. In addition to the visual improvement following surgery, recurrences are prevented by inhibiting astrocyte proliferation.[@b2-opth-9-1483] It is also reported that ILM peeling contributes to the resolution of the macular edema by facilitating the fluid passage from the retina through the vitreous.[@b3-opth-9-1483]

The functional and anatomical outcomes of PPV for ERM and TPH differ in various studies.[@b4-opth-9-1483]--[@b9-opth-9-1483] Despite the improved visual prognosis and the resolution of macular edema following ERM removal, the morphology is rarely conserved.[@b10-opth-9-1483]

Optical coherence tomography (OCT) imaging plays an essential role in the diagnosis and treatment of macular diseases, including those of the vitreomacular interface. The influence of the integrity of the photoreceptor inner/outer segment (IS/OS) junction line and ILM on postoperative visual acuity (VA) and the change in choroidal thickness during the course of the retinopathy can be evaluated more precisely by OCT.[@b11-opth-9-1483],[@b12-opth-9-1483] Pelosini et al[@b13-opth-9-1483] reported an interesting correlation between the VA at the time of the edema and the amount of tissue located between the two plexiform layers on en face OCT scans, and they have shown that retinal tissue integrity could be an indicator of visual function before treatment.

In this study, the relationship between visual outcomes and determinants detected by spectral domain (SD)-OCT in eyes with ERM and/or TPH that underwent PPV was investigated.

Methods
=======

This was a prospective cohort study. The protocol was approved by the ethical committee of the Istanbul Research and Training Hospital (Istanbul, Turkey). All participants signed informed consent forms, and the study adhered to the tenets of the Declaration of Helsinki. The subjects were 30 patients (30 eyes) who underwent surgery after the diagnosis of ERM (ERM group; n=17) and/or TPH (TPH group; n=13) between April 2013 and March 2014.

All participants underwent ophthalmological examinations, including VA and refraction, slit lamp biomicroscopy, applanation tonometry, axial length, and dilated fundoscopy. VA data (Snellen chart) were converted to logarithm of the minimum angle of resolution (logMAR) values. Preoperative central macular thickness (CMT), fundus fluorescein angiography (FFA) findings, laser treatments, and intravitreal injections were recorded.

Eligibility criteria were the diagnosis of diabetic macular edema with diffuse leakage in the FFA and OCT parameters that were stable for the last 4 months after intravitreal bevacizumab or steroid injections. Panretinal scatter laser photocoagulation of all subjects was completed at least 6 months prior to surgery. All eligible patients had panretinal laser photocoagulation treatment and OCT findings were consistent with ERM formation.

The exclusion criteria included any history of uveitis, neurological diseases, retinal vascular occlusion, glaucoma, ocular hypertension, retinal detachment, and vitrectomy. Patients with cataracts, optic atrophy, and laser scars in the macula that would affect the functional results were excluded. Subjects with vitreous hemorrhage, fibrovascular traction affecting the macula, tractional detachment, damaged IS/OS layer integrity, residual ILM, or iatrogenic retinal breaks were also excluded. All eyes were dilated with tropicamide 0.5%, and OCT images were obtained by the same experienced technician. The surgeon was the same (HG) for the 30 patients.

Postoperative CMT, central choroidal thickness (CCT), peripapillary retinal nerve fiber layer (pRNFL) thickness, ganglion cell layer with inner plexiform layer (GCIPL), and ganglion cell complex (GCC) thickness were measured by Topcon 3D OCT-2000 (Topcon Corporation, Tokyo, Japan) ([Figure 1](#f1-opth-9-1483){ref-type="fig"}).

The enhanced depth imaging mode of the OCT was used in the choroidal thickness evaluations. The protocol of the enhanced choroidal mode cross scan was performed, centering on the fovea. This protocol consisted of 6 mm cross lines with 1,024 A-scans/B-scans and overlapping four B-scans per image; direct B-scan observation was available. Choroidal thickness was measured perpendicularly from the outer edge of the retinal pigment epithelium to the choroid--sclera boundary at the fovea, and at five more points, which are sequentially located.

Mean RNFL and GCC thicknesses were measured by SD-OCT, which acquires 26,000 A-scans per second and provides a 5 μm depth resolution in tissue. RNFL thickness was determined by the optic nerve head mode, in which data along a 3.45 mm diameter circle around the optic disc were recalculated with a map created from six circular and 12 linear data inputs. Mean, superior, and inferior thicknesses were calculated. The GCC scan was centered 1 mm temporal to the fovea and covered a square grid (7×7 mm) on the central macula. GCC thickness was measured from the ILM to the outer boundary of the GCIPL, and mean, superior, and inferior GCC thicknesses were calculated.

Images were excluded when the signal strength index was less than 60, when overt misalignment of the surface detection algorithm occurred, or when there was overt decentration of the measurement circle location.

Surgical technique
------------------

After informed consent was obtained, the patient received either general or local anesthesia (posterior subtenon block, using 3 mL of 0.5% bupivacaine and 2% prilocaine). Pupillary dilation was obtained with tropicamide 1% and phenylephrine 2.5% drops prior to surgery. Standard 23 gauge, three-port PPV was then performed using the Alcon Constellation vitrectomy unit (Alcon Laboratories, Inc., Fort Worth, TX, USA). The ERM was identified with intravitreal triamcinolone and peeled using ILM forceps. In all cases with residual traction after ERM peeling, Brilliant Blue dye was injected and the ILM was peeled as well. The vitreous cavity was filled with 10% SF6. All eyes underwent Brilliant Blue dye-assisted ILM peeling with fluid--SF6 exchange, and endolaser photocoagulation was performed anterior to the equator of each eye (if necessary). At the end of the PPV, the patient received a subconjunctival injection of gentamicin and dexamethasone. Postoperatively, all patients received topical prednisolone acetate 1%, lomefloxacin 3 mg/mL, and oral moxifloxacin 400 mg, unless a contraindication was present.

Patients were examined postoperatively at the 1st day, 1st week, 1st month, 3rd month, and 6th month after the surgery. The best corrected VA (BCVA) and OCT parameters were measured at each visit. For data analyses, the BCVA at 6 months after surgery was recorded and converted to logMAR format. (Visual acuities that could not be measured using a Snellen chart were converted using the following algorithm: count fingers =1.6; hand motion =2; light perception =2.5; and no light perception =3). The preoperative and postoperative 6-month data of the BCVA logMAR value difference was calculated and compared in each group and between both groups. The postoperative BCVA logMar value was correlated with preoperative BCVA, age, postoperative CMT, postoperative CCT, postoperative RNFL, postoperative GCC, and image quality.

Statistical analyses were performed using SPSS 20.0 software. The distribution of variables was evaluated using the Kolmogorov--Smirnov test. A comparison of mean BCVA before and after surgery was evaluated using the Wilcoxon test. A comparison of the BCVA between the ERM group and TPH group was analyzed using the Mann--Whitney *U*-test. The correlations between BCVA and OCT parameters were evaluated with Pearson's correlation analysis.

Results
=======

A total of 30 patients (15 men, 15 women) with unilateral ERM or TPH were included. Their mean age was 67.8±8.3 years (range: 49--82 years). Patient demographics and the postoperative OCT parameters of the study population are summarized in [Table 1](#t1-opth-9-1483){ref-type="table"}. The mean postoperative CMT and CCT were 284.8±102.7 μm and 230.8±59.6 μm, respectively. All eyes were pseudophakic before the surgery. All eyes underwent Brilliant Blue dye-assisted ILM peeling with fluid--SF6 exchange, and endolaser photocoagulation was performed anterior to the equator of each eye (if necessary). No intraoperative or postoperative complications occurred in any of the patients.

The mean preoperative BCVA was 0.80±0.28 logMAR, whereas the mean final postoperative BCVA was 0.42±0.28 logMAR (*P*\<0.001) ([Table 2](#t2-opth-9-1483){ref-type="table"}). The postoperative BCVA logMar values were statistically higher than the preoperative values in both groups (*P*=0.001 and *P*\<0.001, respectively). There was a statistically significant correlation between the preoperative and postoperative BCVA (*r*=0.686; *P*\<0.001). There was no significant difference between the ERM group and the TPH group with respect to preoperative and postoperative BCVA logMar value differences (*P*=0.712) ([Table 3](#t3-opth-9-1483){ref-type="table"}).

The postoperative BCVA logMar value was not correlated with age, postoperative CMT, CCT, superior RNFL, temporal RNFL, nasal RNFL, and mean GCC thicknesses (*P*\>0.05), whereas it was negatively correlated with average RNFL, inferior RNFL thicknesses, and image quality (*P*=0.002, *P*=0.004, and *P*=0.006, respectively). The preoperative and postoperative BCVA logMar value difference was not correlated with age or any of the OCT parameters measured (*P*\>0.05) ([Table 4](#t4-opth-9-1483){ref-type="table"}).

Discussion
==========

This study demonstrated that VA (BCVA) after PPV is strongly correlated with preoperative BCVA, as well as postoperative average and inferior pRNFL thicknesses.

ERM is a macular disease that causes decreased vision and metamorphopsia. Vitrectomy and removal of the membrane are the standard treatment for ERM. Recently, this surgical approach has been combined with ILM peeling to reduce ERM recurrence by eliminating the area where myofibroblasts can proliferate.[@b14-opth-9-1483] TPH is also a cause of tangential traction on the retinal surface, thereby inducing or exacerbating edema and producing a tractional retinal detachment as part of the clinical syndrome. The importance of OCT is recognized, and the vitreomacular interface and changes in retinal thickness before and after surgery can be measured.[@b15-opth-9-1483]--[@b17-opth-9-1483]

Previous studies have reported favorable functional and anatomical results after vitrectomy.[@b18-opth-9-1483]--[@b20-opth-9-1483] Their surgical approach was the removal of the posterior hyaloid and tractional forces associated with a thickened and taut premacular hyaloid in patients with diabetic macular edema. The size of the macular capillary dropout area and the IS/OS regeneration in the parafoveal quadrants contribute significantly to the recovery of BCVA following ERM surgery.[@b21-opth-9-1483],[@b22-opth-9-1483] ILM peeling appears to have a significant effect on functional success, whereas only a few studies have reported the effect of ILM peeling on retinal thickness.[@b23-opth-9-1483]--[@b25-opth-9-1483] In this study, it was not possible to evaluate the difference resulting from ILM peeling, as ILM peeling was done and there was IS/OS integrity obtained by OCT in all cases.

Significant changes in VA were obtained in all subjects. After PPV with ILM peeling in both the ERM group and the TPH group, the postoperative BCVA was statistically higher than the preoperative values. There was no significant difference between the ERM group and the TPH group with respect to preoperative and postoperative BCVA logMar value differences. The postoperative BCVA logMar value was negatively correlated with the average RNFL, inferior RNFL thicknesses, and image quality.

CMT values may reflect traction on the retinal ganglion cells, and greater CMT values may be associated with greater traction and, in turn, more severe ganglion cell damage in idiopathic ERM.[@b10-opth-9-1483] In this study, the preexisting metabolic, inflammatory, and vascular factors due to diabetes increased RNFL thickness; and degenerative changes were the additional factors affecting CMT. Since CMT value is considered to decrease in ERM cases postoperatively up to 12 months, the duration of the study is short.[@b10-opth-9-1483] We think that the partial or complete elimination of these factors, as well as microcirculatory changes, specific responses to the surgery, and the long-lasting changes to the macula, might have prevented establishing a relationship between postoperative VA and CMT.

Surgical and laser procedures have variable effects on RNFL thickness in the follow-up period.[@b10-opth-9-1483],[@b26-opth-9-1483] Müller cells produce metabolic and morphological interactions between the retinal vessels and neurons. Hyperglycemia causes Müller cell dysfunction in diabetic patients, and progressive axonal degeneration occurs due to an imbalance between the intra-and extracellular matrix. Changes in the Müller cells give rise to an apoptotic response in these eyes. In several studies, it has been demonstrated by OCT that the inferior GCIPL and RNFL thicknesses are thinner in diabetic patients.[@b26-opth-9-1483] In our study, we evaluated the relationship of RNFL thickness to VA after PPV. The postoperative BCVA logMar value was negatively correlated with the average and inferior RNFL thickness.

VA improvement in patients with idiopathic ERM is closely related to the thickness of the inner retinal layers.[@b10-opth-9-1483],[@b26-opth-9-1483],[@b27-opth-9-1483] As a result of a traction, GCC damage occurs in idiopathic ERM.[@b10-opth-9-1483] Pierro et al[@b28-opth-9-1483] showed that GCC thickness is higher in eyes with idiopathic ERM, and postoperative GCC reduction is proportionally higher than thinning of the whole retina; this reduction is correlated with visual restoration. Bonnin et al[@b29-opth-9-1483] demonstrated that the average and minimum GCIPL thicknesses evaluated by Cirrus high definition-OCT were strongly correlated with VA. However, this work relied on the analysis of inner retinal changes on a dried retina, so this method avoids segmentation errors made by the ganglion cell analyzer and allows for an objective assessment of GCIPL changes in the macula.[@b29-opth-9-1483] Since the early stages of diabetes mellitus affect the inner and outer retinal layers in different ways, they cause progressive neurodegenerative retinal diseases.[@b30-opth-9-1483]--[@b32-opth-9-1483] GCIPL begins to thin in the early stages of diabetic retinopathy among patients with retinopathy.[@b31-opth-9-1483] The progressive loss of ganglion cells and astrocytes leads to a loss of RNFL.[@b31-opth-9-1483],[@b33-opth-9-1483]--[@b36-opth-9-1483] In our study, there was no relationship between the average GCC thickness and postoperative VA. The reason for the preoperative and postoperative BCVA value difference is dependent on metabolic, inflammatory, and vascular factors, as well as on degenerative changes in the retina. The advanced stage of retinopathy suggests a severe neurodegeneration in these cases. The resultant visual function is mainly dependent on the neuronal activity of the retina. The reason for this can include the advanced stage of the cases and not having significant differences between GCIPL values among the cases. The neurodegeneration is expected to cause thinning and atrophy of the RNFL. The correlation between VA and RNFL thickness is compatible with the nature of the disease in cases with advanced diabetic retinopathy.

The number of patients who completed the follow-up examinations for 6 months was small, and it was not possible to conduct any long-term follow-up over 6 months in this study. Furthermore, the software for measuring RNFL was developed for normal eyes, and the ERM may affect the RNFL thickness measurement.[@b37-opth-9-1483] The ability of the software to accurately measure RNFL thickness in these eyes is uncertain because it was not possible to segment the original signals to determine the accuracy of RNFL measurements. For this reason, preoperative OCT measurements were not evaluated.

Conclusion
==========

In conclusion, this study shows that better RNFL thickness achievement results in higher levels of visual outcomes after PPV and ERM/TPH removal. The first studies using SD-OCT showed the importance of IS/OS layer integrity in diabetic eyes. RNFL and GCC thickness were also shown to be very important in eyes with IS/OS layer integrity, and this factor has been reviewed in a recent study.[@b38-opth-9-1483]
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###### 

(**A**) The image of a GCC scan which is centered 1 mm temporal to the fovea and covered a square grid on the central macula. (**B**) The OCT image showing ILM, IS/OS, RPE, and BM. (**C**) The postoperative OCT image of a patient showing retinal nerve fiber layer, ILM and IS/OS, and optic nerve head parameters.

**Abbreviations:** BM, basement membrane; GCC, ganglion cell complex; ILM, internal limiting membrane; IS, inner segment; OCT, optical coherence tomography; OS, outer segment; RPE, retinal pigment epithelium.
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###### 

Demographics and postoperative OCT parameters of the study population

                              Mean ± SD     Median   Minimum--maximum
  --------------------------- ------------- -------- ------------------
  Age                         67.8±8.3      65.5     49.0--82.0
  Preoperative BCVA logMAR    0.80±0.28     0.75     0.32--1.80
  Postoperative BCVA logMAR   0.42±0.28     0.32     0.10--1.51
  CMT                         284.8±102.7   248.5    91.0--593.0
  CCT                         230.8±59.6    243.5    130.0--372.0
  pRNFL average               93.8±17.4     95.5     51.0--126.0
  pRNFL superior              103.3±23.1    106.5    46.0--142.0
  pRNFL inferior              109.6±24.0    109.0    53.0--148.0
  pRNFL temporal              81.3±17.5     82.0     40.0--112.0
  pRNFL nasal                 75.0±25.4     79.0     40.0--164.0
  mRNFL                       59.0±28.4     49.5     28.0--134.0
  GCIPL                       75.3±20.7     71.5     49.0--132.0
  GCC                         106.0±27.9    105.0    66.0--178.0

**Abbreviations:** OCT, optical coherence tomography; SD, standard deviation; BCVA, best corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; CMT, central macular thickness; CCT, central choroidal thickness; pRNFL, peripapillary retinal nerve fiber layer; mRNFL, macular retinal nerve fiber layer; GCIPL, ganglion cell layer + inner plexiform layer; GCC, ganglion cell complex.

###### 

The comparison between preoperative and postoperative BCVA

                   Mean ± SD   Median (minimum--maximum)   *P*
  ---------------- ----------- --------------------------- ---------
  Preoperative                                             
   BCVA (logMAR)   0.80±0.28   0.8 (0.3--1.8)              \<0.001
  Postoperative                                            
   BCVA (logMAR)   0.42±0.28   0.3 (0.1--1.5)              \<0.001

**Abbreviations:** BCVA, best corrected visual acuity; SD, standard deviation; logMAR, logarithm of the minimum angle of resolution.

###### 

The comparison between the preoperative and post- operative logMAR value difference in the study population

                   Mean ± SD   Median (minimum--maximum)   *P*
  ---------------- ----------- --------------------------- -------
  **ERM (n=17)**                                           
  BCVA logMAR                                              
   Preoperative    0.84±0.35   0.7 (0.4--1.8)              0.712
   Postoperative   0.39±0.35   0.3 (0.1--1.5)              0.158
   Difference      0.45±0.22   0.4 (0.2--0.9)              0.191
  **TPH (n=13)**                                           
  BCVA logMAR                                              
   Preoperative    0.77±0.22   0.8 (0.3--1.0)              0.712
   Postoperative   0.45±0.22   0.4 (0.2--0.8)              0.158
   Difference      0.34±0.25   0.3 (0.1--0.8)              0.191

**Abbreviations:** logMAR, logarithm of the minimum angle of resolution; ERM, epiretinal membrane; BCVA, best corrected visual acuity; TPH, taut posterior hyaloid; SD, standard deviation.

###### 

The correlation between postoperative BCVA logMAR value, age, and OCT parameters

                               *r*      *P*
  ---------------------------- -------- -----------
  Age                          −0.068   0.712
  Preoperative BCVA (logMAR)   0.686    **0.000**
  CMT                          −0.265   0.157
  CCT                          −0.513   0.438
  pRNFL average                −0.541   **0.002**
  pRNFL superior               −0.331   0.074
  pRNFL inferior               −0.506   **0.004**
  pRNFL temporal               −0.170   0.369
  pRNFL nasal                  −0.532   **0.002**
  mRNFL                        −0.029   0.888
  GCIPL                        −0.086   0.676
  GCC                          −0.169   0.421

**Note:** Bold font indicates that the correlations are statistically significant.

**Abbreviations:** BCVA, best corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; OCT, optical coherence tomography; CMT, central macular thickness; CCT, central choroidal thickness; pRNFL, peripapillary retinal nerve fiber layer; mRNFL, macular nerve fiber layer; GCIPL, ganglion cell layer + inner plexiform layer; GCC, ganglion cell complex.
